GGrantIndex
← Leaderboards

Cedars-Sinai Medical Center

West Hollywood, CA

Compare ↔
$1,387,453,225
Total funding
1,037
Grants

Funding over time

peak $136.8M · FY2005–25
$200M$150M$100M$50M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$1,244,847,363 · 909
DOD$128,182,503 · 111
AHRQ$5,141,186 · 7
CDC$3,794,632 · 1
NSF$2,801,225 · 5
FDA$2,280,870 · 2
DOE$405,446 · 2

By mechanism

R01$817,329,022 · 437
—$131,389,174 · 118
U01$111,796,520 · 25
P01$97,688,658 · 96
R21$38,403,174 · 100
U54$27,023,810 · 39

Investigators at Cedars-Sinai Medical Center

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Hsin-Jung Yang$4,002,3513 gr2Celine E. Riera$2,591,6201 gr3Ivan Cokic$2,478,8202 gr4Stan Jordan$2,216,5251 gr5Nirmala Mavila$1,679,8931 gr6Linda Y. Kim$1,398,7271 gr7Russell Rogers$1,153,6571 gr8Changfu Yao$1,126,2821 gr

Emerging Leaders

6–10 yrs in

1Magali Noval Rivas$6,076,5493 gr2Zhaoyang Fan$3,556,6393 gr3Anthony G Christodoulou$3,424,1674 gr4David Ouyang$3,150,0143 gr5Megan P Hitchins$2,976,1862 gr6James F. Dawkins$2,915,8791 gr7Caroline Jefferies$2,694,8722 gr8Dmitriy Sheyn$2,692,0372 gr

All-Time

Most funded here, all years

1Mitchell Kronenberg$36,151,45318 gr2Shelly Chi-Loo Lu$28,110,37513 gr3Jerome I. Rotter$26,286,5237 gr4Homayon Ghiasi$23,294,44610 gr5Moshe Arditi$22,646,84218 gr6Eduardo Marban$18,938,98910 gr7Stephan R. Targan$17,286,5007 gr8Alexander V Ljubimov$16,915,6258 gr

Largest grants

MECHANISMS AND TREATMENT DEVELOPMENT FOR PANCREATITIS RESULTING FROM ALCOHOL ABUSE AND SMOKING$10,000,000
· FY2019 · Defense Health Agency
HEART FAILURE WITH PRESERVED EJECTION FRACTION: MECHANISMS AND NOVEL THERAPEUTICS$10,000,000
· FY2016 · Department of the Army
Cedars-Sinai Biobank and Translational Research Core Facility (CS-BRCF)$9,552,872
G20 · FY2010 · RR
THERAPEUTIC DEVELOPMENT OF NONCODING RNA DRUG TY1 FOR SCLERODERMA$6,146,874
· FY2025 · Defense Health Agency
Assessment of Biomarker Guided CNI Substitution in Kidney Transplantation$5,352,674
U01 · FY2025 · AI
MILITARY OPERATING ROOM OF THE FUTURE$5,244,000
· FY2011 · Department of Defense
ULTRASOUND-MEDIATED NANOBIOMATERIAL DELIVERY FOR SEGMENTAL BONE FRACTURE REPAIR$4,915,532
· FY2018 · Department of the Army
Assessment of Biomarker Guided CNI Substitution in Kidney Transplantation$4,209,374
U01 · FY2023 · AI
Assessment of Biomarker Guided CNI Substitution in Kidney Transplantation$4,138,693
U01 · FY2022 · AI
Molecular Transducers of Physical Activity Consortium Adult Clinical Center$4,100,000
U01 · FY2023 · AR
OVERCOMING IMMUNOTHERAPY RESISTANCE IN BREAST CANCER USING RT-MEDIATED IMMUNOMODULATION$3,789,131
· FY2019 · Department of the Army
AI Methods for Large Scale Epidemiological Studies using Patient Reports of Medication Adherence and Tolerability$3,484,662
R01 · FY2025 · LM
Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2$3,386,294
U54 · FY2020 · CA
THERAPEUTIC TARGETING OF BREAST CANCER AND HOST IMMUNE RESPONSES AT INFLECTION POINTS IN THE DISEASE TRAJECTORY$3,339,835
· FY2021 · Defense Health Agency
Barber-Pharmacist Coordination to Improve Blood Pressure Management in Black Men$3,049,123
R01 · FY2015 · HL
DEFINING HUMAN CORRELATES OF SUPER-EVASIVE DISSEMINATED TUMOR CELLS, THEIR PATHOLOGICAL RELEVANCE AND HOW TO ERADICATE THEM$2,685,519
· FY2025 · Defense Health Agency
IDENTIFYING PATHWAYS OF PROGRESSION OF ACUTE PANCREATITIS TO RECURRING ACUTE PANCREATITIS AND CHRONIC PANCREATITIS$2,674,057
· FY2025 · Defense Health Agency
Assessment of Biomarker Guided CNI Substitution in Kidney Transplantation$2,641,189
U01 · FY2024 · AI
Hypothalamic Pathways of Age Related Homeostatic Dysregulation$2,591,620
RF1 · FY2025 · AG
OVERCOMING IMMUNOTHERAPY RESISTANCE IN BREAST CANCER USING RT-MEDIATED IMMUNOMODULATION$2,540,008
· FY2019 · Defense Health Agency